Related Experiment Video
Updated: May 14, 2026
09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Altered Purkinje cell miRNA expression and SCA1 pathogenesis.
Edgardo Rodriguez-Lebron1, Gumei Liu, Megan Keiser
1Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA.
Neurobiology of Disease
|February 5, 2013
Summary
MicroRNAs (miRNAs) are deregulated in spinocerebellar ataxia type 1 (SCA1), a neurodegenerative disorder. This study found altered miRNA levels in SCA1 mouse models, suggesting miRNAs like miR-150 impact disease progression.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease linked to polyglutamine expansions in Ataxin-1.
- MicroRNA (miRNA) deregulation is implicated in SCA1 pathogenesis, but their precise role is unclear.
Purpose of the Study:
- To investigate miRNA misregulation in the cerebellum of a mouse model of SCA1.
- To determine if miRNA alterations occur before and after the onset of SCA1 symptoms.
Main Methods:
- Utilized a mouse model of spinocerebellar ataxia type 1 (SCA1).
- Analyzed miRNA expression levels in pre- and post-symptomatic cerebellar tissues.
Main Results:
- Identified significant alterations in numerous miRNA steady-state levels in SCA1 mice, both before and after symptom onset.
- Demonstrated increased miR-150 levels in SCA1 Purkinje neurons.
- Provided evidence that miR-150 targets Rgs8 and Vegfa expression, potentially modulating SCA1 pathogenesis.
Conclusions:
- MicroRNA expression is significantly altered in the SCA1 cerebellum during disease progression.
- miR-150 upregulation in Purkinje neurons may play a role in SCA1 pathogenesis by affecting Rgs8 and Vegfa.
